Search Results - "Albieri, Benedetta"

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma by Nielsen, Morten, Monberg, Tine, Sundvold, Vibeke, Albieri, Benedetta, Hovgaard, Dorrit, Petersen, Michael Mørk, Krarup-Hansen, Anders, Met, Özcan, Camilio, Ketil, Clancy, Trevor, Stratford, Richard, Sveinbjornsson, Baldur, Rekdal, Øystein, Junker, Niels, Svane, Inge Marie

“…LTX-315 is an oncolytic peptide that elicits both local and systemic immune responses upon intratumoral injection. In the present pilot trial, we treated…”
Get full text

First in man study: Bcl-Xl_42-CAF ® 09b vaccines in patients with locally advanced prostate cancer by Mørk, Sofie Kirial, Kongsted, Per, Westergaard, Marie Christine Wulff, Albieri, Benedetta, Granhøj, Joachim Stoltenborg, Donia, Marco, Martinenaite, Evelina, Holmström, Morten Orebo, Madsen, Kasper, Kverneland, Anders H, Kjeldsen, Julie Westerlin, Holmstroem, Rikke Boedker, Lorentzen, Cathrine Lund, Nørgaard, Nis, Andreasen, Lars Vibe, Wood, Grith Krøyer, Christensen, Dennis, Klausen, Michael Schantz, Hadrup, Sine Reker, Thor Straten, Per, Andersen, Mads Hald, Svane, Inge Marie

“…The B-cell lymphoma-extra-large (Bcl-XL) protein plays an important role in cancer cells' resistance to apoptosis. Pre-clinical studies have shown that…”
Get full text

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma by Mørk, Sofie Kirial, Skadborg, Signe Koggersbøl, Albieri, Benedetta, Draghi, Arianna, Bol, Kalijn, Kadivar, Mohammad, Westergaard, Marie Christine Wulff, Stoltenborg Granhøj, Joachim, Borch, Annie, Petersen, Nadia Viborg, Thuesen, Nikolas, Rasmussen, Ida Svahn, Andreasen, Lars Vibe, Dohn, Rebecca Bach, Yde, Christina Westmose, Noergaard, Nis, Lorentzen, Torben, Soerensen, Anders Bundgaard, Kleine-Kohlbrecher, Daniela, Jespersen, Anders, Christensen, Dennis, Kringelum, Jens, Donia, Marco, Hadrup, Sine Reker, Marie Svane, Inge

“…BackgroundNeoantigens can serve as targets for T cell-mediated antitumor immunity via personalized neopeptide vaccines. Interim data from our clinical study…”
Get full text

918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes by Draghi, Arianna, Chamberlain, Christopher A, Khan, Shawez, Harbst, Katja, Presti, Mario, Lauss, Martin, Crowther, Michael D, Jensen, Agnete WP, Rasmussen, Anne-Christine K, Albieri, Benedetta, Lorentzen, Torben, Andersen, Mads H, Jönsson, Göran, Svane, Inge, Donia, Marco

“…BackgroundImmunotherapy has demonstrated impressive results in numerous metastatic solid tumors. However, while most studies have focused on immune responses…”
Get full text

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes in patients with metastatic soft tissue sarcoma by Nielsen, Morten, Monberg, Tine, Albieri, Benedetta, Sundvold, Vibeke, Rekdal, Oystein, Junker, Niels, Svane, Inge Marie

“…11567 Background: Adoptive cell transfer (ACT) with tumor-infiltrating lymphocytes (TILs) is a potent treatment that can induce complete and durable tumor…”
Get full text

Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma by Draghi, Arianna, Presti, Mario, Jensen, Agnete W P, Chamberlain, Christopher A, Albieri, Benedetta, Rasmussen, Anne-Christine K, Andersen, Mads H, Crowther, Michael D, Svane, Inge Marie, Donia, Marco

“…Impaired MHCI-presentation and insensitivity to immune effector molecules are common features of immune checkpoint blockade(ICB)-resistant tumors and can be…”
Get full text

Final results: Dose escalation study of a personalized peptide-based neoantigen vaccine in patients with metastatic melanoma by Mørk, Sofie Kirial, Skadborg, Signe Koggersbøl, Albieri, Benedetta, Draghi, Arianna, Westergaard, Marie Christine Wulff, Granhøj, Joachim Stoltenborg, Kadivar, Mohammad, Thuesen, Nikolas, Rasmussen, Ida Svahn, Yde, Christina Westmose, Nørgaard, Nis, Lorentzen, Torben, Petersen, Nadia Viborg, Jespersen, Anders, Christensen, Dennis, Kringelum, Jens Vindahl, Donia, Marco, Hadrup, Sine Reker, Svane, Inge Marie

“…9551 Background: Despite the advances made with CPIs such as aPD-1/aPD-L1, aCTL4 and aLAG-3 there still is a significant unmet medical need for patients with…”
Get full text